Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Chemidex Pharma Ltd., T/A Essential Generics, Chemidex House, Egham Business Village, Crabtree Road, Egham, Surrey, TW20 8RB, United Kingdom
Conditions for which alpha blockade is indicated.
Management of urinary outflow obstruction due to benign prostatic hyperplasia.
20 mg twice daily.
Dosage may be increased in 20 mg increments at two-weekly intervals up to max. 100 mg per day if required.
20 mg at night may be adequate.
Not recommended.
For oral administration.
Information available at present of the effects of acute overdosage in human beings with indoramin is limited. Effects seen have included deep sedation leading to coma, hypotension and fits. Results of animal work suggest that hypothermia may also occur.
Suggested therapy is along the following lines:
Temperature should be closely monitored. If hypothermia occurs, rewarming should be carried out very slowly to avoid possible convulsions.
3 years.
Store below 25°C.
Blister packs – packs of 60.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.